Oracle (ORCL) Health and Life Sciences and the Cancer Center Informatics Society, a nonprofit uniting cancer centers, researchers, and industry innovators, are collaborating to advance AI innovation in oncology care and research. The collaboration aims to bring together Oracle’s technology with Ci4CC’s Initiatives Program and national network of NCI-Designated and Community Care Cancer Centers. The two organizations plan to collaborate to design an EHR optimized for cancer care. “Cancer remains a leading cause of death worldwide, but AI and data science have become powerful allies in the fight,” said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. “Combining Ci4CC’s unparalleled expertise and network with our state-of-the-art proven AI-powered healthcare applications, we have the opportunity to accelerate discoveries that can help cure cancer.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORCL:
- AI Daily: Apple said to use Google model to run new Siri assistant
- Amazon Stock ‘Has Gone from the Laggard to the Leader,’ Says Fund CEO after $300B Rally
- “Don’t Count AMD Stock Out” Top Analyst Assigns New Street-High Price Target after Q3 Beat
- OpenAI partner Crusoe nears $120M employee stock sale, The Information says
- Top Baird, Stifel Analysts Lift AMD Stock Price Target on Chip Giant’s Q3 Beat